"Kancer Limited aims to be a leading development based company in cancer treatments"

    Kancer Business Model:

  • Focussing funds spent on controlled risk and high opportunity projects;

  • Minimisation of organisational overheads through strategic business collaborations and appropriate outsourcing;

  • Combine in-house development with targeted international collaborations to expand portfolio;

  • Commitment to good corporate governance and scientific practices;  

  • Out-licence products, if appropriate, in Phase II of development;

  • Reserve certain co-promotional rights if  appropriate to build a future specialist sales capability; and  

  • Use the national and international capital markets to finance progress.









 2008 Kancer Limited | Disclaimer